No Data
Kintara Therapeutics Eyes Acquisition Amidst Cautionary Advice
TuHURA Biosciences And Kintara Therapeutics Announce Agreement For Potential Acquisition Of Kineta's Anti-VISTA Antibody
Express News | Kintara Therapeutics Inc - Under Terms of Agreement, Tuhura Will Pay Kineta $5.0 Mln
Express News | Tuhura Biosciences Enters Into Exclusivity and Right of First Offer Agreement for Kineta, Inc.'s Kva12123 Novel Anti-Vista Checkpoint Inhibitor
Kintara Therapeutics Outlines Progress and Potential Risks
Express News | Kintara Therapeutics and Tuhura Biosciences Provide Update on Recent Corporate and Clinical Advancements and Outline Near Term Milestones
No Data
Lnova : do you know when the merger conclusion is gonna be? Just a general timeframe
Youngbuffet OP Lnova : they always finalize the merger on or before the quarter that they initially mentioned, they don't always specify the actual date but actual quarter in the biotech mergers have experienced so far. by end of next month everything should be concluded on or before then. Have been holding since April.